Forteo (Teriparatide [rDNA origin]) for Osteoporosis

Overview
Forteo is a prescription drug approved by the Food and Drug Administration (FDA) to treat postmenopausal women with osteoporosis who are at high risk for fracture. Forteo is also indicated to treat men with hypogonadal osteoporosis and people with osteoporosis induced by glucocorticoid steroids such as prednisone who are at high risk for fracture. Forteo may be referred to by its drug name, Teriparatide [rDNA origin].

Forteo is a synthetic version of parathyroid hormone (PTH). Forteo is believed to work by stimulating the activity of osteoblasts, the cells that build bone.

How do I take it?
Forteo is administered once a day as a subcutaneous injection.

Forteo comes in the form of a multi-dose prefilled pen.

Side effects
The FDA-approved label for Forteo lists common side effects including nausea and pain, especially joint pain.

Rare but serious side effects listed for Forteo include increased risk for osteosarcoma (malignant bone tumor), the formation of kidney or bladder stones, and orthostatic hypotension (dizziness upon standing up).

For more details about this treatment, visit:

Forteo - Eli Lilly and Company
https://www.forteo.com/